Limor Chen, Ph.D

Regulatory Project Manager

Limor has over 14 years of R&D management experience in Israel biotech industry. His expertise are in various therapeutic areas such as immunotherapy, oncology, drug delivery and vaccines. His scientific training included working in leading medical institution in the Israel, US and Canada developing novel therapies for cancer,

Before joining Gsap he held the position of VP Clinical Development in Vaxil Bio, a cancer vaccine company. Formerly he served as Director of Business Development at BiondVax Pharmacuticals, developing regulatory strategies for commercialization in the US and the EU. In BioLineRx he was as a Drug Development Manager, leading multiple early stage pharmaceutical and device programs towards clinical stages and commercialization. Before that Limor served as a project leader at Teva Pharmaceuticals’ special projects unit, developing various products under 505(b)(2) pathway.

Limor earned his PhD at the Weizmann Institute of Science, in the departments of Immunology and Biophysics and was a postdoctoral fellow at MD Anderson Cancer Center in Houston, Texas and at the Sunnybrook Research Institute in Toronto.